Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CVS

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com

CVS and Walgreens limit sales of children's meds as the 'tripledemic' drives demand

Walgreens will limit online orders of children's fever and pain medicine to six items "to help support availability and avoid excess purchases." At CVS stores, purchases will be limited to two.

WEKU

2 Monster Growth Stocks to Buy Now

The Fed has indicated that it will keep raising interest rates through next year. However, despite the economic uncertainties, the revival of the U.S. economy in the second half of this year has made experts hopeful of a mild recession ahead. Hence, it could be wise to invest in monster-growth…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

StockNews.com

Walgreens, CVS agree to pay $10 billion to settle lawsuits linked to opioid sales

Most of the money is to be used to fight the overdose epidemic. The deals are among the largest of proposed and finalized settlements over the opioid crisis totaling over $50 billion.

Chicago Sun-Times

CVS and Walgreens agree to pay $10 billion to settle lawsuits linked to opioid sales

CVS would pay about $5 billion and Walgreens more than $5.5 billion, though neither company has admitted wrongdoing. States have until the end of the year to accept the terms of the settlement.

WEKU

Read news from The Economist, FT, and more,
with one subscription

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

1 No-Brainer Stock to Buy When the Market Plunges

CVS Health (CVS) beat revenue and EPS estimates for the 2022 third quarter. Moreover, the stock has gained more than 10% over the past year despite the market turmoil. Also, it currently pays its shareholders a more than 2% dividend. Therefore, CVS might be an ideal buy amid challenging times.…

StockNews.com

How the best leaders are preparing to navigate a recession—and come out ahead

Current and former corporate leaders share their battle-tested playbooks with Fortune.

Fortune

You’ve got COVID — but what are the rules these days?

FORT LAUDERDALE, Fla. -- Someone at your office had COVID a few days ago and is now back at their desk in the cubicle next to yours. That can’t be okay, can it?

Tribune News Service

Varo Bank Review 2022: For the customer who prefers mobile banking and a 5.00% APY over the brick-and-mortar experience

Varo Bank offers only a few products, but for no-frills customers, this online-bank could be the right fit.

Fortune

3 Hot Stocks With More Room to Run in 2023

As inflation shows signs of easing and the Fed is expected to slow the pace of rate hikes, the market’s prospects look bright. Therefore, fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Box (BOX) could keep soaring. Wall Street analysts expect upsides in these stocks over the next 12…

StockNews.com

Amazon vs Walmart: Who Has the Cheapest Prices?

Amazon handily beat Walmart for the lowest prices on food and consumables, a study shows. In other categories, things tightened up.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

4 Stocks That Can Help Fire up Your Portfolio This Winter

Recent data indicates the signs of slowing down inflation. Additionally, the Fed is leaning toward slowing its pace of rate hikes. Amid this, fundamentally strong stocks Johnson & Johnson (JNJ), CVS Health (CVS), Douglas Dynamics (PLOW), and Genie Energy (GNE) might be ideal additions to your portfolio this winter. Continue…

Fortune

How CEOs can lead in a recession and come out stronger: 5 powerful strategies from corner-office veterans

Battle-tested business leaders from CVS, Southwest Airlines, Honeywell and other Fortune 500 companies share their best ideas for navigating a downturn.

The Independent UK

Terrell Owens says man he punched at CVS threatened him, fan

Retired NFL star Terrell Owens said a fight caught on camera in which he punched a man in a CVS parking lot was the result of an “aggressor” threatening him and a fan he was talking to at the California store

The Independent UK

Delphi murders: What we know about suspect Richard Allen

Richard Allen is a married 50-year-old man who worked in the local CVS store in the heart of Delphi – where Libby German and Abby Williams lived with their families

Get all your
news in one place.

100’s of premium titles.
One news app.

The Philadelphia Inquirer

Why the tourniquet, a relic from the earliest days of medicine, is back amid the gun violence epidemic

PHILADELPHIA —The way the blood spurted from the bullet wound, Lt. Robert Friel knew he didn't have long.

StockNews.com

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

Tribune News Service

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Chicago Sun-Times

Be prepared: Surge of winter sickness likely on its way, city’s top doc says

If you haven’t had your COVID-19 fall 2022 booster, now is the time, Chicago Public Health Commissioner Dr. Allison Arwady said.

StockNews.com

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com

2 Dividend Stocks That Can See Your Portfolio Through Tough Times and Beyond

The market has been under pressure amid high inflation, rising interest rates, and a slowing economy. Amid lingering macro headwinds, dividend investing could help investors ensure a steady income stream. Therefore, quality dividend stocks, CVS Health (CVS) and Spok Holdings (SPOK) could be ideal investments to navigate through tough times…

Al Jazeera

Walmart offers $3bn to settle lawsuits over role in opioid crisis

Tentative agreement would bring settlement total from lawsuits against various companies to more than $50bn.

1 … 16 17 18 19

People

Kritika SarmahHer

727 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.